[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].

Wolfgang Hilbe, Kurt Aigner, Christian Dittrich, Josef Eckmayr, Michael Fiegl, Martin Flicker, Bernhard Forstner, Richard Greil (Co-author), Herbert Jamnig, Gerhard Krajnik, Alois Lang, Andrea Mohn-Staudner, Herwig Schinko, Michael Studnicka (Co-author), Robert Pirker, Ferdinand Ploner, Johannes Rothmund, Lothar Schiller, August Zabernigg, Sabine Zöchbauer-Müller

Research output: Contribution to journalReview articlepeer-review

12 Citations (Web of Science)
Original languageGerman
Pages (from-to)259-266
JournalWIENER KLINISCHE WOCHENSCHRIFT
Volume119
Issue number7-8
DOIs
Publication statusPublished - 2007

Keywords

  • PHASE-III TRIAL
  • PLATINUM-BASED CHEMOTHERAPY
  • ELDERLY-PATIENTS
  • RANDOMIZED-TRIAL
  • DOCETAXEL
  • NICOTINE
  • SMOKING
  • SURVIVAL
  • GEMCITABINE
  • VINORELBINE

Cite this